Tag: Biotechnology

SAN FRANCISCO, Calif. /Florida Newswire - National News/ -- Neurotech Reports, the publisher of the Neurotech Business Report newsletter, announced that two prominent figures in the field of neurotechnology will keynote the 2025 Neurotech Leaders Forum, which takes place November 5-6 in San Francisco. Edward Chang, chair of the department of neurological surgery at UC San Francisco, will discuss future applications of implanted brain sensing and stimulation devices.

CEDAR PARK, Texas /Florida Newswire - National News/ -- Zeteo Biomedical, a privately held biomedical device company, today announced the issuance of new patents in the United States and European Union for its advanced drug delivery technologies. The patents, titled "Cartridge Devices for Administration of a Medicament" (U.S. Patent No. 12329949) and "Hand-Operated Devices for Administration of a Medicament" (EU Patent No. 3946526), further strengthen Zeteo's ZTech™ delivery platform portfolio for the administration of drugs and biologics via nasal, ophthalmic, and sublingual routes.

NEW YORK, N.Y. /Florida Newswire - National News/ -- Amerigo Scientific unveils its line of different-sized bioconjugated fluorescent nanodiamonds (FNDs), designed to redefine precision in cellular and in vivo imaging. These bioconjugated FNDs are provided to address critical challenges in high-resolution diagnostics, targeted drug delivery, and real-time biological tracking, positioning itself as a game-changer for researchers and scientists alike.

PHILADELPHIA, Pa. /Florida Newswire - National News/ -- Redox Therapeutics announces the signing of an exclusive license agreement with The Curators of the University of Missouri acting by and through the Missouri University of Science and Technology (Missouri S&T) for a patented polymer nanoparticles technology designed for endotoxin removal from fluids such as water, protein solutions and plasma.

NEW YORK, N.Y., March 17, 2025 (SEND2PRESS NEWSWIRE) -- Neurotech Reports, the publisher of the Neurotech Business Report and BioElectRx Business Report newsletters, announced that the Eighth Annual Bioelectronic Medicine Forum will take place on April 10, 2025. The one-day event will be held at the New York Academy of Medicine in Manhattan.

SAN FRANCISCO, Calif., Jan. 30, 2025 (SEND2PRESS NEWSWIRE) -- Neurotech Reports, the longest-serving publishing and market intelligence firm covering the neuromodulation industry, announced the launch of its first European management and investment conference. The two-day event, called Neurotech Leaders Forum at imec, will take place on June 3-4, 2025 on the campus of imec in Leuven, Belgium. Imec, a world-leading research and innovation center in nanoelectronics and digital technologies, is deeply committed to advancing health innovations through the power of semiconductor technologies, making it the ideal host for the conference.

ATLANTA, Ga., Feb. 1, 2024 (SEND2PRESS NEWSWIRE) -- Divergent CRO, a leading provider of clinical services to biotech and device companies, is pleased to announce the official launch of its new Contract Research Organization (CRO). This new venture aims to revolutionize the research and development process by offering comprehensive and tailored clinical services to meet the unique needs of the biotech and device industries.

AUSTIN, Texas, Feb. 1, 2024 (SEND2PRESS NEWSWIRE) -- BioAustinCTX, Central Texas' Life Science industry organization, announced today the appointment of Cindy WalkerPeach, PhD and Ryan Hawkins to its Board of Directors. BioAustinCTX is a nonprofit organization based in Austin, Texas focused on advancing the life science industry in the Central Texas Region.

LOS ANGELES, Calif., Sept. 25, 2023 (SEND2PRESS NEWSWIRE) -- Neo-Bionica, a leading innovator in the field of medical device development and manufacturing, is thrilled to announce the appointment of Uli Gommel as its new Chief Technology Officer (CTO). Uli will lead Neo-Bionica's technology division spearheading its mission to revolutionize the way that companies bring novel neurotechnologies and smart MedTech devices to market.

CHESAPEAKE, Va., May 19, 2023 (SEND2PRESS NEWSWIRE) -- A new universal vaccine method developed by Eric Kikkert is outlined in an article he wrote called: "The Slammer Method: How to create effective vaccines." It recently appeared in the "Journal of Infectious Diseases and Therapy" and is proposed to work in not just humans, but animals too. The material was presented at the 2023 12th International Conference for Tropical Medicine and Infectious Disease in London, received an award and established as a universal method to create effective vaccines.

NEW YORK, N.Y., March 7, 2023 (SEND2PRESS NEWSWIRE) -- Neurotech Reports, the publisher of the Neurotech Business Report and BioElectRx Business Report newsletters, announced that the Sixth Annual Bioelectronic Medicine Forum will take place on April 4, 2023. The one-day event will be held at the New York Academy of Medicine in Manhattan.

SCOTTSDALE, Ariz., Oct. 18, 2022 (SEND2PRESS NEWSWIRE) -- Dosaggio™ by SottoPelle® and PatientNow announced today that they have entered into a partnership that integrates the two companies' innovative technologies, to improve efficiencies and elevate patient care for providers offering bioidentical hormone replacement therapy (BHRT).

SCOTTSDALE, Ariz., Sept. 28, 2022 (SEND2PRESS NEWSWIRE) -- Dosaggio™ by SottoPelle® and Cerbo announced today that they have entered into a partnership that integrates the two companies' innovative technologies, to improve efficiencies and elevate patient care for providers offering bioidentical hormone replacement therapy (BHRT).

SEATTLE, Wash., Sept. 8, 2022 (SEND2PRESS NEWSWIRE) -- Proteios Technology, Inc. is pleased to announce it's received a $1.6 million SBIR Phase II grant from the National Institutes of Health (NIH) to commercialize its multivariate (parallel) cell isolation technology. Grant funds will be used to extend Proteios' cell isolation kits to include up to 20 of the most common cell types currently used in cell therapy development.

ROCHESTER, Minn., April 6, 2022 (SEND2PRESS NEWSWIRE) -- Vyriad, Inc., a clinical-stage biotechnology company developing oncolytic virus therapies to treat a wide range of cancers, today announced results confirming the activity of an oral vaccine formulation for boosting immunity against SARS-CoV-2. The full study conducted on nonhuman primates is published in the journal Vaccine.

OKLAHOMA CITY, Okla., AUSTIN, Texas and MELBOURNE, Australia, April 6, 2022 (SEND2PRESS NEWSWIRE) -- Pure MHC, LLC and Myrio Therapeutics Pty Ltd (Myrio) today announced a collaboration to develop new antibody-based oncology therapeutics. The companies will combine Pure MHC's proprietary offering of MHC peptide targets for oncology with Myrio's revolutionary Retained Display(tm) (ReD) antibody discovery process to initially create up to three novel therapies based on targets distinct to tumors across multiple types of cancer.

GENEVA, Switzerland, and NEW YORK, N.Y., April 5, 2022 (SEND2PRESS NEWSWIRE) -- Neurosoft Bioelectronics, an early-stage company developing tools for unmet needs in epilepsy and tinnitus, was awarded nearly $3 million USD, from the SERI-Funded European Innovation Council Accelerator Grant and a share of the $165,000 USD through the European Research Council Proof-of-Concept Grant.

NEW YORK, N.Y., March 28, 2022 (SEND2PRESS NEWSWIRE) -- Neurotech Reports, the publisher of the Neurotech Business Report and BioElectRx Business Report newsletters, announced that founders and CEOs of several promising bioelectronic medicine startups will present at the Fifth Annual Bioelectric Medicine Forum on April 5, 2022. The event will take place in New York City, although participation via Zoom videoconference will be accommodated.

AUSTIN, Texas and BARCELONA, Spain, Feb. 15, 2022 (SEND2PRESS NEWSWIRE) -- Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a research collaboration with Vall d'Hebron Barcelona Hospital Campus to develop new technologies for B-cell monitoring in transplant rejection.

AUSTIN, Texas and OXFORD, U.K., Dec. 7, 2021 (SEND2PRESS NEWSWIRE) -- Pure Transplant Solutions, LLC (PTS), a developer of novel HLA based transplant diagnostics, and Oxford Immunotec, Ltd. (OI), a global diagnostics company part of PerkinElmer Inc., today announce an exclusive sublicense agreement in which PTS will obtain exclusive commercial rights to issued patents protecting a novel assay originally developed by Dr. Oriol Bestard, M.D., Ph.D.